-
Overview of Vaccines
Most vaccines are designed as a prophylactic measure, that is, to stimulate the
2025-06-19 49 -
Oxidative Stress and Beta Cell Dysfunction
Autoimmune Type 1 A Diabetes (T1D) is characterized by dependence on exogenous i
2025-06-19 53 -
p27 ELISA
ProcedureDilute p27 monoclonal antibody 1:1000 (v/v) in Carbonate Coating Buffer
2025-06-19 50 -
PAMPs and DAMPs in Allergy Exacerbation Models
Sensitization of mice to real-life allergens or harmless antigen with the use of
2025-06-19 47 -
Passive Immunization with Human Neutralizing Monoclonal Antibodies Against HIV-1 in Macaque Models:
After more than 20 years of intense research, a safe and effective vaccine again
2025-06-19 50 -
Pathogenesis and Spectrum of Autoimmunity
The immune system specifically recognizes and eliminates foreign antigens and th
2025-06-19 37 -
Pathogenesis of Multiple Sclerosis: What Can We Learn from the Cuprizone Model
Multiple sclerosis is an inflammatory demyelinating and neurodegenerative disord
2025-06-19 39 -
Pathology of Systemic Lupus Erythematosus: The Challenges Ahead
Many studies have explored the pathology of systemic lupus erythematosus (SLE),
2025-06-19 42 -
Paul Ehrlichs ;Mastzellen From Aniline Dyes to DNA Chip Arrays: A Historical Review of Developments
It has been more than a century since the discovery of the mast cell by the geni
2025-06-19 48 -
PCR of the V Region
To engineer or manipulate antibody or Fv-based molecules, isolation of the V reg
2025-06-19 46 -
PCR-Restriction Fragment Length Polymorphism Typing of Class I and II Alleles
Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) as
2025-06-19 55 -
PCR-Sequence-Specific Oligonucleotide Probe Typing for HLA-A, -B, and -DR
The advantages of using molecular methods instead of serological typing to defin
2025-06-19 60 -
PCR-Sequence-Specific Primer Typing of HLA Class I and Class II Alleles
The use of molecular typing methods for defining human leukocyte antigen (HLA) C
2025-06-19 68 -
PEGylation of Antibody Fragments for Half-Life Extension
Antibody fragments (Fab’s) represent important structure for creating new therap
2025-06-19 59 -
PEGylation of Antibody Fragments to Improve Pharmacodynamics and Pharmacokinetics
Covalent attachment of polyethylene glycol (PEG) with therapeutic proteins (PEGy
2025-06-19 62
